NuWave Investment Management’s Moderna MRNA Stock Holding History

NuWave Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$420K	Sell	3,548 -3,810	-52%	-$578K	0.48%	74
2022 Q2	$1.05M	Buy	7,358 +2,539	+53%	+$363K	1.4%	7
2022 Q1	$830K	Buy	4,819 +1,644	+52%	+$277K	1.11%	16
2021 Q4	$806K	Buy	3,175 +688	+28%	+$201K	0.91%	22
2021 Q3	$957K	Buy	+2,487	New	+$917K	1.09%	16
2021 Q2	–	Sell	-2,902	Closed	-$380K	–	388
2021 Q1	$380K	Sell	2,902 -1,509	-34%	-$219K	0.48%	71
2020 Q4	$461K	Buy	4,411 +4,080	+1,233%	+$413K	0.6%	49
2020 Q3	$23K	Buy	+331	New	+$23.1K	0.04%	293

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NuWave Investment Management's MRNA Position: Q3 2022 in Review

NuWave Investment Management reduced its Moderna (MRNA) stake by 52% in Q3 2022, selling an estimated $578K and leaving 3,548 shares worth $420K. The position accounts for 0.48% of the portfolio, ranked #74.

NuWave Investment Management first reported a position in MRNA in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.05M in Q2 2022. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

NuWave Investment Management held 3,548 shares of Moderna worth $420K as of Q3 2022.
NuWave Investment Management sold 3,810 Moderna shares in Q3 2022, an estimated $578K.
Moderna made up 0.48% of NuWave Investment Management's portfolio in Q3 2022, its #74 holding.
NuWave Investment Management first reported a position in Moderna in Q3 2020 and has held it in 8 quarters since.
NuWave Investment Management's Moderna position peaked at $1.05M in Q2 2022.
916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.